Related Experiment Video

Updated: Aug 27, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

6.2K

Induction of JAK2/STAT3 pathway contributes to protective effects of different therapeutics against myocardial

Sina Mahdiani1, Navid Omidkhoda2, Ramin Rezaee3

  • 1Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|September 26, 2022
PubMed

Insights

Therapeutics activating the Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway can protect the heart from damage caused by myocardial ischemia/reperfusion (IR) injury.

Area of Science:

  • Cardiovascular Science
  • Molecular Medicine
  • Biochemistry

Background:

  • Myocardial ischemia/reperfusion (IR) injury, resulting from insufficient coronary blood supply and subsequent reperfusion, causes irreversible heart damage.
  • Key pathological mechanisms include oxidative stress, inflammation, reactive oxygen species (ROS) generation, and apoptosis.
  • The Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway is implicated in cardioprotection against IR injury.

Purpose of the Study:

  • To review therapeutic strategies that protect the heart against myocardial IR injury.
  • To explore the role of the JAK2/STAT3 signaling pathway in mediating these cardioprotective effects.

Main Methods:

  • Literature review of existing research on myocardial IR injury.
  • Analysis of studies investigating therapeutics targeting the JAK2/STAT3 pathway.
  • Synthesis of evidence on the mechanisms of cardioprotection.

Main Results:

  • Several therapeutic agents have demonstrated cardioprotective effects against IR injury.
  • Activation of the JAK2/STAT3 pathway is a common mechanism underlying the efficacy of these therapeutics.
  • Targeting the JAK2/STAT3 pathway offers a promising strategy for mitigating myocardial IR injury.

Conclusions:

  • The JAK2/STAT3 pathway plays a critical role in protecting the myocardium from IR injury.
  • Therapeutics inducing JAK2/STAT3 activation represent a potential treatment modality for acute myocardial infarction.
  • Further research into JAK2/STAT3-activating agents could lead to novel cardioprotective therapies.
Keywords:
AlleviateBrainHeartIschemia

More Related Videos

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

527
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.3K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K